Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

237.10

+0.54 (0.23%)

At close: Aug 28, 2026, 4:00 PM EDT

240.00

+2.90 (1.22%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	31,726	52,535	30,350	24,021	29,238	20,282
Market Cap Growth	-46.71%	73.09%	26.35%	-17.84%	44.16%	34.32%
Enterprise Value	31,405	52,584	30,296	24,278	29,564	19,873
Last Close Price	237.10	397.65	235.31	191.41	237.65	169.58

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	42.19	167.44	-	-	-	-
Forward PE	28.91	60.03	-	-	-	-
PS Ratio	6.60	14.15	13.50	13.14	28.18	24.02
PB Ratio	23.42	66.57	452.40	-108.87	-184.79	34.48
P/TBV Ratio	23.43	66.57	452.40	-	-	34.48
P/FCF Ratio	38.70	112.89	-	572.67	-	-
P/OCF Ratio	34.79	100.24	-	230.62	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.54	14.16	13.48	13.28	28.50	23.54
EV/EBITDA Ratio	29.78	94.37	-	-	-	-
EV/EBIT Ratio	31.41	104.84	-	-	-	-
EV/FCF Ratio	38.31	112.99	-	578.81	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	2.21	3.76	40.89	-12.16	-16.51	3.72
Debt / EBITDA Ratio	2.64	4.70	-	-	-	-
Debt / FCF Ratio	3.64	6.38	-	63.96	-	-
Net Debt / Equity Ratio	-0.24	0.08	0.73	-1.10	-2.65	-0.42
Net Debt / EBITDA Ratio	-0.30	0.11	-0.41	-1.07	-0.57	0.38
Net Debt / FCF Ratio	-0.39	0.13	-1.15	5.80	-0.68	0.35
Asset Turnover	0.95	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	11.58	8.46	3.86	2.85	1.57	1.74
Quick Ratio	2.79	2.51	2.61	2.86	3.17	3.79
Current Ratio	3.06	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	96.56%	73.28%	-	-	-526.14%	-106.31%
Return on Assets (ROA)	12.34%	6.81%	-2.74%	-4.78%	-13.65%	-12.56%
Return on Invested Capital (ROIC)	96.60%	100.88%	-11.88%	-10.01%	-50.38%	-132.10%
Return on Capital Employed (ROCE)	24.70%	14.30%	-5.80%	-9.90%	-28.30%	-24.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.44%	0.60%	-0.92%	-1.83%	-3.87%	-4.21%
FCF Yield	2.58%	0.89%	-0.14%	0.18%	-2.10%	-3.54%
Buyback Yield / Dilution	-7.12%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%

SEC Filings: 10-K · 10-Q